Veracity Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,425
Closed -$206K 210
2024
Q1
$206K Sell
7,425
-2,461
-25% -$68.3K 0.08% 201
2023
Q4
$285K Sell
9,886
-324
-3% -$9.79K 0.11% 164
2023
Q3
$339K Sell
10,210
-179
-2% -$6.33K 0.16% 131
2023
Q2
$381K Sell
10,389
-1,806
-15% -$70.3K 0.16% 132
2023
Q1
$498K Sell
12,195
-522
-4% -$22.5K 0.23% 102
2022
Q4
$652K Buy
12,717
+528
+4% +$25.3K 0.31% 74
2022
Q3
$533K Sell
12,189
-360
-3% -$17.5K 0.29% 82
2022
Q2
$658K Sell
12,549
-5
-0% -$255 0.35% 69
2022
Q1
$650K Buy
12,554
+3,561
+40% +$185K 0.27% 89
2021
Q4
$531K Buy
8,993
+781
+10% +$38.7K 0.21% 116
2021
Q3
$353K Sell
8,212
-468
-5% -$20.7K 0.15% 156
2021
Q2
$337K Sell
8,680
-100,208
-92% -$3.9M 0.08% 183
2021
Q1
$675K Buy
108,888
+536
+0.5% +$19K 0.14% 162
2020
Q4
$665K Sell
108,352
-5,087
-4% -$187K 0.17% 156
2020
Q3
$646K Sell
113,439
-1,368
-1% -$48K 0.18% 147
2020
Q2
$627K Buy
114,807
+94,284
+459% +$3.2M 0.18% 141
2020
Q1
$636K Sell
20,523
-5,975
-23% -$204K 0.18% 98
2019
Q4
$985K Buy
+26,498
New +$944K 0.25% 92

Other funds holding PFE

Veracity Capital's PFE Position: Q2 2024 in Review

Veracity Capital sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,425 shares — an estimated $206K sold.

Veracity Capital first reported a position in PFE in Q4 2019 and held it in 18 quarters. The position peaked at $985K in Q4 2019. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Veracity Capital reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Veracity Capital sold 7,425 Pfizer shares in Q2 2024, an estimated $206K.
  • Veracity Capital first reported a position in Pfizer in Q4 2019 and held it in 18 quarters.
  • Veracity Capital's Pfizer position peaked at $985K in Q4 2019.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Veracity Capital's 13F filing for Q2 2024, filed 22 Jul 2024.